News Releases
FOR IMMEDIATE RELEASE
- Knipper VPs to Speak on eSampling and Sample Accountability at Pharma Conference CBInet.com
-
LAKEWOOD, NJ – March 7, 2005
Ihab Ghaly, Vice President, Sampling and Regulatory Affairs, and Dave Hammond, Vice President, Sales and Marketing, of J. Knipper and Company, Inc., will speak at CBI’s 5th Annual Forum on Sample Accountability in Princeton, NJ, on May 16-17, 2005.
Hammond and Ghaly will speak on “Leveraging Web-Based eSampling and Solutions to Enable Real-Time, Cost-Effective Drug Sample Management”. Web-based administration tools enable pharmaceutical companies to effectively manage their drug-sampling activities. These tools include sample distribution, inventory management, electronic signature audits and exception management. They also help pharmaceutical companies in complying with PDMA and 21 CFR Part 11 guidelines.
“Ghaly and Hammond are very sought-after speakers on the range of Sample Accountability issues,” said James J. Knipper, CEO/President of the pharmaceutical marketing services company. “They are two of the reasons our company is a leader in Sample Accountability in the healthcare industry. They have been intimately involved in the development of our new purely paperless eSampling platform which allows manufacturers to increase their market share and brand penetration while reducing their direct costs through the use of a true electronic sampling system that is 21 CFR Part 11 compliant”.
Ghaly has over 14 years of managerial experience in sales and marketing, manufacturing, distribution, regulatory affairs, and QA. He is a member of the New Jersey Pharmaceutical Quality Control Association.
Hammond has over 25 years of experience in sales and senior management. He is a member of the board of directors of the PDMA Sharing Conference and the Healthcare Marketing < Communications Council.
Both Hammond and Ghaly are frequent speakers on pharmaceutical industry marketing trends and sample practices and have been interviewed in a number of pharmaceutical industry publications.
Knipper is an executive sponsor of the CBI conference, which is designed to utilize technology and best practices to build state and federal compliant programs. Attendees will hear case studies from prominent pharmaceutical companies and have the chance to network.
Press contact:
Jim Knipper, CEO J. Knipper and Company, Inc. Tel.: 888-KNIPPER Jim.Knipper@knipper.comAbout J. Knipper and Company
Founded in 1986, J. Knipper and Company, Inc. provides healthcare marketing solutions in direct marketing, sampling, compliance, information technology, and salesforce productivity. Going beyond its roots in direct marketing and sample distribution, Knipper continues to offer innovative solutions to salesforce challenges, including MyPharmaRep.com (online solution for vacant-territory coverage), MySampleCloset.com (online sample ordering), and Knipper HealthAdvantage (bundling of pharma samples with consumer products). The company has invested considerably in its physical and data infrastructure over the years: the company currently has 270,000 square feet of space, with 12,000 of that refrigerated and 7,500 for controlled substances, along with an advanced Data Center, fully protected for the secure and safe handling of database management and sample supplies. Knipper is one of a handful of companies approved as an AMA DBL (database licensee).